Nektar Therapeutics (NKTR)

Add to Watchlists
Create an Alert
10.97 -0.07  -0.68% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
NKTR Price Chart
View All Events

NKTR Events

Date Type Description
Feb 26 Misc Nektar Therapeutics, Inc. Q4 2013 Earning Conference Call
Feb 26 Earnings Nektar Therapeutics, Inc. Q4 2013 Earning Result. Estimate: -0.16.
Nov 07 Misc Nektar to Announce Financial Results for the Third Quarter Conference Call
Nov 07 Earnings Nektar to Announce Financial Results for the Third Quarter Earnings Results. Estimate: -0.24.
Oct 08 Misc Nektar Reports on Advancements With Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&d Day
Sep 26 Misc Nektar Conference Call
Aug 08 Misc Second Quarter of 2013 Conference Call
Aug 08 Earnings Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of u.s.-based Financial Markets. Estimate: -0.44.
Jun 13 Misc AGM Event for Nektar Therapeutics
May 09 Misc Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
View All Performance Charts

NKTR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Nektar Therapeutics is up 0.73% over the last year vs S&P 500 Total Return up 20.96%, Alexion Pharmaceuticals up 55.82%, and Aratana Therapeutics up N/A.

Get Quote for

PDF Report for NKTR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NKTR Pro Report PDF

Portfolio Strategies Featuring NKTR

Did Nektar Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NKTR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NKTR 10.97 -0.07 -0.68% 1.389B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.